Connect with us

Hi, what are you looking for?

Stock

European shares struggle ahead of speeches from ECB policymakers

(Reuters) -European shares dipped on Monday following a string of weekly losses, weighed down by real estate and technology stocks, while investors awaited speeches from European Central Bank policymakers to gauge the path of interest rates.

The continent-wide STOXX 600 index dropped 0.2% by 0909 GMT.

The benchmark posted its first four-week losing streak in 2-1/2 years on Friday, hit by disappointing earnings, a jump in Treasury yields and concerns about the impact of U.S. President-elect Donald Trump’s policies on global economies and businesses.

European tech shares dipped 0.6% ahead of AI bellwether Nvidia (NASDAQ:NVDA)’s quarterly results on Wednesday. Most major sectors were lower, with real estate stocks leading declines.

Investors awaited speeches from ECB chief economist Philip Lane and President Christine Lagarde later in the day as well as euro zone November flash PMIs on Friday for clues on the path of interest rates.

“We think this week’s PMI readings are unlikely to fully reflect recent political highlights and should therefore not be expected to stray far from the most recent, subdued readings,” Unicredit (BIT:CRDI) analysts said in a note.

ECB Vice President Luis de Guindos said global trade tensions further the risk for an already weak euro zone economy. Another policymaker, Joachim Nagel, said the tariffs promised by Trump would upend international trade but may ultimately have a “minor impact” on inflation.

Traders are pricing in a 72% chance of a 25 bps rate cut by the ECB in December, and see cuts of 142 bps by the end of next year.

Britain’s Melrose (LON:MRON) Industries rose 8.6% after the owner of aerospace parts maker GKN (LON:GKN) Aerospace reported a 7% rise in revenue for the four-month period ended Oct. 31.

Dutch technology investor Prosus (OTC:PROSF) climbed 1.3% after its trading statement.

Grifols (BME:GRLS) fell 2.8% after news website El Confidencial reported Canadian fund Brookfield planned to offer about 7 billion euros ($7.4 billion) for the Spanish drugmaker.

This post appeared first on investing.com






    You May Also Like

    Editor's Pick

    Sen. JD Vance (R-Ohio) and Minnesota Gov. Tim Walz (D) will face off Tuesday night at a CBS News vice-presidential debate in New York....

    Latest News

    A North Korean defector who escaped to the South more than a decade ago was detained after attempting to cross back into North Korea...

    Economy

    A U.N. human rights group confirmed Hamas’ leader in Lebanon, who was recently killed by Israeli strikes, was their employee.  Fateh Sherif was killed...

    Investing

    Astron (ASX:ATR) and Energy Fuels (TSX:EFR,NYSEAMERICAN:UUUU) have completed the establishment of a joint venture to advance the Australia-based Donald rare earths and mineral sands...

    Disclaimer: balanceandcharge.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 balanceandcharge.com